NDC Active Ingredient Vorinostat
Active Ingredient Information
What is Vorinostat?
A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
What is the usage for Vorinostat?
Vorinostat is used to treat a certain type of cancer (CTCL-cutaneous T-cell lymphoma). It works by slowing or stopping the growth of cancer cells.
How many products in the NDC database contain Vorinostat?
The NDC database has 5 products with the active ingredient Vorinostat. The following table lists all the products that have this active ingredient.
NDC Products with Vorinostat
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0006-0568 | Proprietary Name: Zolinza | Vorinostat | Capsule | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
63285-009 | Proprietary Name: | Vorinostat | Capsule | Patheon Inc. | ACTIVE | ||
65392-3101 | Proprietary Name: | Vorinostat Coarse | Powder | Curia New York, Inc. | ACTIVE | ||
65392-3102 | Proprietary Name: | Vorinostat Fine | Powder | Curia New York, Inc. | ACTIVE | ||
86184-423 | Proprietary Name: | Vorinostat | Powder | Maeda Inc | ACTIVE |